Class IOngoingD-0573-2023
Drug recall · May 10, 2023
DYNAMITE SUPER capsule recall
Why: Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
DYNAMITE SUPER capsule, 58,000 MG, 1-count blister card, Made in America, UPC 6 75799 37602 7.
- Lots / codes
Lot/Item#: OMS760-B, Exp: 12/2025
- Quantity
- 140 blister packs
- Company
- Gadget Island, Inc, West Sacramento, CA
- Distribution
- Nationwide in the USA.
- Initiated
- April 26, 2023 · Voluntary: Firm initiated
- Classified
- May 11, 2023
- Reported
- May 10, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.